Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter
Access to hospital-based eye care and reimbursement were policy topics at the…
Phase 2 data for kamuvudine K8, an investigational inflammasome-directed treatment from Inflammasome…
Two transactions announced in September and October 2026 show capital moving through…
GenSight Biologics and the Quinze-Vingts National Ophthalmology Hospital in Paris announced on…
Photo of Camiel Boon at the 2025 EURETINA meeting in Paris, France…
(Image Credit: AdobeStock/Photocreo Bednarek) Character Biosciences has expanded its leadership team with…
(Image credit: AdobeStock/hakule) Optos and Toku have reached an agreement to make…
Photo of Robyn Guymer at EURETINA 2025 in Paris, France Professor Robyn…
iVeena Delivery Systems has been awarded a $2 million phase 2 Small…
Christine Kay, MD, a vitreoretinal surgeon and IRD specialist from Gainesville, Florida,…
In celebration of Ophthalmology Times‘ 50th anniversary, we asked leading experts in…
(Image credit: AdobeStock/matrosovv) Virtual Vision Health and VirtuaLens have entered a strategic…
(Image credit: AdobeStock) Klinge Biopharma GmbH (“Klinge”), the exclusive owner of the…
Enter your email address below and subscribe to our newsletter